Deftbiotech is a biotech startup developing peptide-based antifungal treatments for nail and skin infections.
Deftbiotech has raised $1.0M in total funding. The most recent round was Pre-Seed. The last funding was announced in March 2026.
Deftbiotech's investors include La Trobe University, Breakthrough Victoria.
Deftbiotech is headquartered in Hawthorn, Australia.
Deftbiotech is a biotech startup developing peptide-based antifungal treatments for nail and skin infections.
Deftbiotech is at the Pre-Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Deftbiotech — Funding & Investors." VCBacked, March 20, 2026, https://www.vcbacked.co/company/deftbiotech. Accessed August 14, 2026.
VCBacked. (2026). Deftbiotech — Funding & Investors. Retrieved August 14, 2026, from https://www.vcbacked.co/company/deftbiotech
{{cite web |title=Deftbiotech — Funding & Investors |url=https://www.vcbacked.co/company/deftbiotech |website=VCBacked |access-date=August 14, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated